rethinkPeptides Search
Menu
Research citation

Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease.

Alimentary pharmacology & therapeutics, 50(5), 547-555

Citation

Truitt, Kenneth E; Daveson, A James M; Ee, Hooi C; Goel, Gautam; MacDougall, James; Neff, Kristin; Anderson, Robert P. (2019). Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease.. Alimentary pharmacology & therapeutics, 50(5), 547-555. https://doi.org/10.1111/apt.15435